Atlas Trials

Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis

Clinical trial NCT00534794 · COMPLETED

Trial details

NCT number
NCT00534794
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Allergic Conjunctivitis
Start date
2007-10-01
Primary completion
2008-01-01
Enrollment
79

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.